BioCryst Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 25 16:32 ET
BioCryst Pharmaceuticals | DEFA14A: Others
Apr 25 16:27 ET
BioCryst Pharmaceuticals | DEF 14A: Definitive information statements
Apr 25 16:22 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.
Apr 2 16:27 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
Mar 4 17:51 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HEGGIE THERESA
Mar 4 16:36 ET
BioCryst Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 27 17:14 ET
BioCryst Pharmaceuticals | 10-K: Annual report
Feb 27 16:16 ET
BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
Feb 26 07:10 ET
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Felix J. Baker(4.98%),Julian C. Baker(4.98%), etc.
Feb 14 17:47 ET
BioCryst Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)
Feb 14 09:07 ET
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.67%)
Feb 13 18:08 ET
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)
Jan 24 17:32 ET
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.24%)
Jan 24 13:10 ET
BioCryst Pharmaceuticals | 8-K: Current report
Jan 18 00:00 ET
BioCryst Pharmaceuticals | 8-K: Current report
Jan 8 00:00 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P
Jan 4 00:00 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thackray Helen M.
Dec 20, 2023 16:42 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stonehouse Jon P
Dec 20, 2023 16:40 ET
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Gayer Charles K
Dec 20, 2023 16:38 ET
No Data
No Data